Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluates prochlorperazine maleate versus placebo for the prophylaxis of Acute Mountain Sickness; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCHLORPERAZINE MALEATE (prochlorperazine maleate)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Mountain Sickness | Phase 2 | Status: COMPLETED